These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7879032)

  • 1. Renal transplant morphology after long-term therapy with cyclosporine.
    Mihatsch MJ; Morozumi K; Strøm EH; Ryffel B; Gudat F; Thiel G
    Transplant Proc; 1995 Feb; 27(1):39-42. PubMed ID: 7879032
    [No Abstract]   [Full Text] [Related]  

  • 2. Morphological criteria of chronic rejection: differential diagnosis, including cyclosporine nephropathy.
    Mihatsch MJ; Ryffel B; Gudat F
    Transplant Proc; 1993 Apr; 25(2):2031-7. PubMed ID: 8470264
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence of cyclosporine-associated arteriolopathy in renal transplant biopsies from 1981 to 1992.
    Strøm EH; Thiel G; Mihatsch MJ
    Transplant Proc; 1994 Oct; 26(5):2585-7. PubMed ID: 7940802
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on morphological outcome of cyclosporine-associated arteriolopathy after discontinuation of cyclosporine in patients with renal allografts.
    Morozumi K; Thiel G; Gudat F; Mihatsch MJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):537-9. PubMed ID: 8438404
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies of cyclosporine-associated arteriolopathy in renal transplantation: does the long-term outcome of renal allografts depend on chronic cyclosporine nephrotoxicity?
    Takeda A; Morozumi K; Yoshida A; Uchida K; Tominaga Y; Fujinami T; Yokoyama I; Takagi H
    Transplant Proc; 1994 Apr; 26(2):925-8. PubMed ID: 8171705
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclosporine nephrotoxicity: how does it affect renal allograft function and transplant morphology?
    Morozumi K; Takeda A; Uchida K; Mihatsch MJ
    Transplant Proc; 2004 Mar; 36(2 Suppl):251S-256S. PubMed ID: 15041348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal allograft infarction is a cause of early kidney transplant loss in the cyclosporine A era.
    Andrés A; Mazuecos A; Morales JM; Praga M; Martinez MA; Usera G; Araque A; Rodicio JL
    Transplant Proc; 1994 Oct; 26(5):2544-5. PubMed ID: 7940784
    [No Abstract]   [Full Text] [Related]  

  • 8. Is cyclosporine-associated glomerulopathy a new glomerular lesion in renal allografts using CyA?
    Takeda A; Morozumi K; Uchida K; Yokoyama I; Takagi H; Yoshida A; Fujinami T; Thiel G; Gudat F; Mihatsch MJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):515-7. PubMed ID: 8438396
    [No Abstract]   [Full Text] [Related]  

  • 9. Progressive systemic sclerosis and renal transplantation: a contraindication to ciclosporin.
    Ruiz JC; Val F; de Francisco AL; de Bonis E; Zubimendi JA; Prieto M; Canga E; Arias M
    Nephron; 1991; 59(2):330-2. PubMed ID: 1956502
    [No Abstract]   [Full Text] [Related]  

  • 10. Vasculopathy in cyclosporine-treated renal allografts: possible protection by diltiazem.
    Choy BY; Walker RG; Becker GJ
    Clin Transplant; 1994 Jun; 8(3 Pt 1):271-3. PubMed ID: 8061366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine A directly constricts intrarenal arterioles.
    Abraham JS; Bentley FR; Garrison RN; Cryer HM
    Transplant Proc; 1991 Feb; 23(1 Pt 1):356-9. PubMed ID: 1990551
    [No Abstract]   [Full Text] [Related]  

  • 12. [Perivascular hyalin substance and calcinosis of the gingiva after cyclosporin A therapy--a new finding].
    Sharaf MN; Hofstädter F
    Pathologe; 1992 Apr; 13(2):117-20. PubMed ID: 1376475
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of cyclosporine in renal transplantation.
    Kyriakides G; Miller J
    Transplant Proc; 2004 Mar; 36(2 Suppl):167S-172S. PubMed ID: 15041330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of renal mass on chronic kidney allograft rejection in rats.
    Heemann UW; Azuma H; Tullius SG; Mackenzie HS; Schmid C; Brenner BM; Tilney NL
    Transplant Proc; 1995 Feb; 27(1):549. PubMed ID: 7879094
    [No Abstract]   [Full Text] [Related]  

  • 15. The beneficial effects of isradipine on renal hemodynamics in cyclosporine-treated renal transplant recipients.
    McCrea JB; Francos GF; Burke JF; Michael HJ; Besarab A
    Transplantation; 1993 Mar; 55(3):672-4. PubMed ID: 8456491
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of acute renal transplant rejection with FK 506 in patients on cyclosporine after failure of standard antirejection therapy.
    Scott-Douglas N; Zimmerman D; Klassen J
    Transplant Proc; 1996 Dec; 28(6):3165. PubMed ID: 8962226
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunophenotype of infiltrating cells in protocol renal allograft biopsies from tacrolimus-versus cyclosporine-treated patients.
    Serón D; O'Valle F; Moreso F; Gomà M; Hueso M; Grinyó JM; Garcia del Moral R
    Transplantation; 2007 Mar; 83(5):649-52. PubMed ID: 17353788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of animal models of chronic vascular rejection.
    Dennis MJ; Beckingham IJ; Blamey RW
    Transplant Proc; 1993 Apr; 25(2):2102. PubMed ID: 8470285
    [No Abstract]   [Full Text] [Related]  

  • 19. Optimization of the use of cyclosporine in renal transplantation.
    Yoshimura N; Okamoto M; Akioka K; Kaihara S
    Transplant Proc; 2004 Mar; 36(2 Suppl):181S-185S. PubMed ID: 15041333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with cyclosporine in pediatric renal transplantation.
    Willetts IE; Trompeter RS
    Transplant Proc; 2004 Mar; 36(2 Suppl):211S-215S. PubMed ID: 15041339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.